- Research article
- Open Access
Co-operative inhibitory effects of hydrogen peroxide and iodine against bacterial and yeast species
BMC Research Notesvolume 6, Article number: 272 (2013)
Hydrogen peroxide and iodine are powerful antimicrobials widely used as antiseptics and disinfectants. Their antimicrobial properties are known to be enhanced by combining them with other compounds. We studied co-operative inhibitory activities (synergism, additive effects and modes of growth inhibition) of hydrogen peroxide and iodine used concurrently against 3 bacterial and 16 yeast species.
Synergistic or additive inhibitory effects were shown for hydrogen peroxide and iodine mixtures against all 19 species used in the study. Both biocides were mostly cidal individually and in mixtures against Pseudomonas aeruginosa and Staphylococcus aureus. Both compounds manifested static inhibitory effects individually, but their mixtures were synergistically cidal for Saccharomyces cerevisiae and Escherihia coli. Cells of S. cerevisiae treated with hydrogen peroxide and iodine-hydrogen peroxide mixture produced increased numbers of respiratory deficient mutants indicating genotoxic effects.
Iodine and hydrogen peroxide used concurrently interact synergistically or additively against a range of prokaryotic and eukaryotic microorganisms. The study provides an insight as to how these traditional antimicrobials could be used more effectively for disinfection and antisepsis. In addition, a simple approach is proposed for scoring genotoxicity of different biocides by using the budding yeast system.
Antimicrobials are extensively utilized for infection and microbial control in health care, industry and the environment . They are also used for medical treatments . Combining antimicrobials could enhance their activities (via additive effects or synergism) and could help to overcome acquired microbial resistance to single chemicals .
Iodine (I2) and hydrogen peroxide (H2O2) are oxidizing agents with a long history of usage as antimicrobials [1–6]. Iodine is a halogen releasing agent manifesting rapid bactericidal, fungicidal, virucidal and sporicidal effects caused by inhibiting DNA synthesis and attacking amino acids, nucleotides and fatty acids [1, 7]. It is often used in complexes (iodophores) with solubilising agents [1, 7]. Hydrogen peroxide is a peroxygen used for efficient control of various bacteria (especially Gram-positive), their spores, yeasts and viruses - due to the formation of free OH-radicals breaking DNA and oxidizing thiol-groups of proteins and lipids . Both compounds are common antiseptics and disinfectants in topical skin therapy [4, 8], wound healing [2, 7, 9–11], preparation of preoperative sites , control of gingival plaques , treating biofilms  and Fournier’s gangrene , disinfection of catheters  and other surfaces , industrial treatments of fish eggs [18, 19], reducing bacterial pathogens on fruits , purification of water systems  and many other processes.
Some problems associated with side effects and acquired microbial resistance to single antimicrobials could be minimised by using them at lower concentrations in combination. Prerequisites for decreasing concentrations of biocides should be their synergistic or additive effects in mixtures. Increased antimicrobial activities of hydrogen peroxide were shown in combinations with other compounds including hypothiocyanite , sodium bicarbonate , rifampicin , neucoproine , chlorhexidine , different organic acids [20, 27] as well as with UV-irradiation . Synergies were reported also for iodine combined with an essential oil , hyaluronan , chlorhexidine gluconate , polyacrylonitrile .
A few sporadic studies on combining iodine and hydrogen peroxide have been reported [32–34], but the nature of interactions between these compounds and the potential use of this combination against various microorganisms were not studied. In this study, we compared inhibitory effects and modes of action of iodine and hydrogen peroxide used separately and in mixtures against 3 bacterial and 16 yeast species.
Results and discussion
Enhanced growth inhibition of 16 yeast species exposed to hydrogen peroxide and iodine concurrently
In preliminary experiments, 2 mM iodine or 6 mM hydrogen peroxide (in solid YEPD medium) completely inhibited the growth of all tested S. cerevisiae haploid strains (data not shown). In spot tests carried out for 16 different yeast species (Figure 1; Additional file 1: Table S1) on solid YEPD medium containing 1 mM iodine and 1.5 mM hydrogen peroxide, haploid strains DLY 640 and DLY 641 (S. cerevisiae) were the most sensitive to iodine; strains Turbo, ade-1 (S. cerevisiae), GDH 2346, NCPF 3327, GRI 382 (C. albicans ), species C. tropicalis and Bullera alba were slightly inhibited by this biocide; the remainder of the strains were not affected by iodine (Figure 1a). None of the strains was inhibited by 1.5 mM hydrogen peroxide. The mixture of both biocides completely inhibited the growth of all species.
These data show that all yeast species manifested cessation of their growth in the response to concurrent applications of iodine and hydrogen peroxide at concentrations allowing growth when the antiseptics were used separately. Therefore, it is very likely that this co-operative inhibitory capacity of the iodine-hydrogen peroxide mixture could be extended to many others, if not all, yeast species. Depending on the extent of microbial growth inhibition by any two combined substances, the interactions between them could be described as synergistic or additive [1, 35]. To potentially extrapolate our results on prokaryotes, we investigated in more details the nature of inhibitory effects of iodine and hydrogen peroxide used separately and concurrently against three bacterial species, alongside with a budding yeast strain.
Separate antimicrobial effects of hydrogen peroxide and iodine
We tested antimicrobial effects of hydrogen peroxide and iodine against budding yeast (S. cerevisiae) and three bacterial species (Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus) grown in liquid culture.
MIC values of each compound varied for different species (Additional file 2: Table S2). S. cerevisiae and S. aureus were more sensitive to iodine than E. coli and P. aeruginosa. No visible growth of S. cerevisiae was detectable at 300 μM I2. 400 μM was a critical iodine concentration for S. aureus. The growth inhibition of E. coli and P. aeruginosa was observed only at 600 μM I2.
S. aureus showed the highest sensitivity to H2O2. As no visible growth was detected at 200 μM H2O2, this concentration was taken as MIC. MIC of H2O2 for E. coli was 800 μM, for S. cerevisiae and P. aeruginosa it was 4 mM, which is 20 times higher than for S. aureus (Table S2).
In conclusion, various microorganisms manifested different sensitivities to iodine and hydrogen peroxide.
Combined inhibitory effects of hydrogen peroxide and iodine
In mixtures of hydrogen peroxide and iodine, inhibitory concentrations were lower than for the individual compounds in liquid cultures of all tested species (Table 1). Criteria for synergism or additive effects are based on calculations of FIC and FICs values. FIC of a compound is the ratio of MIC value for this compound in the mixture to MIC value for this compound alone. The lower the FIC value is, the more effective inhibitory effect takes place in a mixture. The sum of FIC values (FICs = FICa + FICb) determines interpreting the mode of inhibitory interactions between individual compounds (a and b) in a mixture [26, 36]. For E. coli, at different combinations of hydrogen peroxide-iodine concentrations FICs indexes were in range 0.58-0.79 (less than 1) that could be interpreted as a strong additive interaction or a weak synergism [26, 37]. Similar results were obtained for P. aeruginosa with FICs values between 0.58 and 0.75. For S. cerevisiae and S. aureus the effect of the interaction was additive, with FICs indexes around 1. Taking the definition of synergism at FICs values less than 0.5 [27, 38] we could interpret our results as additive inhibitory effects.
Recovery of inhibited cells
To test modes of inhibition (cell death or growth arrest) caused by hydrogen peroxide and iodine, cells inhibited by treatments were washed twice, spread on plates without antimicrobials, and incubated under conditions permissive for growth. Different species manifested diverse abilities to recover the growth after inhibition by individual and mixed compounds.
Cells of P. aeruginosa treated with the individual compounds at MICs (600 μM for iodine and 4 mM for hydrogen peroxide) did not recover (Additional file 3: Figure S1). No recovery of P. aeruginosa was also found after combined treatments, even at concentrations lower than MIC values for each compound. For example, the mixture (200 μM I2 + 1.5 mM H2O2), where concentration of iodine was 3 times lower and concentration of H2O2 was 2.7 times lower than for individual MICs, killed cells of P. aeruginosa irreversibly.
There were no viable cells after treatment of S. aureus with 400 μM iodine (MIC), but substantial amounts of cells were viable after treatment with 250 μM hydrogen peroxide (MIC for H2O2 is 200 μM). Small amounts of CFU were found in 2 out of 3 tested combinations of both antimicrobials, (250 μM I2 + 75 μM H2O2) and (100 μM I2 + 150 μM H2O2), with 33 colonies and 32 colonies respectively (both from undiluted cultures). No colonies appeared from the mixture (300 μM I2 + 150 μM H2O2). We concluded that for S. aureus iodine is more cidal than hydrogen peroxide (Additional file 3: Figure S2).
The above data suggest that cells of P. aeruginosa and S. aureus were killed more effectively by iodine and hydrogen peroxide used in mixtures rather than individually, and that inhibitory effects were achieved at lower concentrations of the antiseptics due to synergism.
Cells of S. cerevisiae treated either with iodine or hydrogen peroxide recovered after applications of these compounds at all tested concentrations. No recovery was observed after combined treatments at lower concentrations (Additional file 3: Figure S3). Similarly, no recoveries of cell divisions were observed after combined treatments of E. coli with two antiseptics (cidal effects), while recoveries took place after individual treatments with either iodine or hydrogen peroxide (Additional file 3: Figure S4). These data indicate that at least some proportions of treated cells of S. cerevisiae and E. coli were not able to divide due to static effects. The combined treatments of these species resulted in complete loss of their viabilities, implying that synergism led to cidal action.
Cidal effects are more advantageous than static ones, in terms of effectiveness. Therefore, combined treatments with iodine-hydrogen peroxide could be more effective approach in many aspects of disinfection and topical treatments associated with these antiseptics. Particular advantages of the combined treatments could be related to reduced concentrations of the antimicrobials that could be important for reducing their side effects [39, 40]. Another advantage would be prevention of microbial resistance that could be acquired to single biocides [41, 42].
Our experiments were carried out in vitro on pure cultures of microorganisms. Application of the co-operative inhibitory effects to in vivo clinical conditions including potentially mixed infections and biological substrates will require additional trials. However, a recent clinical study demonstrated effective reductions of post-operational infections by using combined treatments with PVP-iodine and hydrogen peroxide after spine surgeries .
Iodine enhances incidence of respiration deficiencies in yeast cells treated with hydrogen peroxide
Treatments of budding yeast cells with hydrogen peroxide and mixtures hydrogen peroxide-iodine (followed by washing with water) increased numbers of small colonies on solid YEPD. Their largest numbers (36.8% of total colony number) were produced by cells treated with hydrogen peroxide at concentration 3 mM (Figure 1b). After treatment with 1.5 mM hydrogen peroxide the slight increase in the number of small colonies (18% as average) was not statistically significant as compared with control (11% of small colonies). Treatments with up to 200 mM iodine did not increase numbers of small colonies (12%). However, cells treated with the mixture of hydrogen peroxide-iodine (1.5 mM + 200 μM respectively) produced 34% of small colonies suggesting a co-operative effect between hydrogen peroxide and iodine. Under these treatment conditions cells were clearly inhibited but were still able to grow.
We reasoned that small colonies might present the petite mutants associated with mutations in mitochondrial DNA leading to respiratory deficiencies. The petite mutants are not able to grow under respiration conditions, for example, on glycerol or ethanol . Indeed, most of randomly selected individual small colonies from treatments with 3 mM hydrogen peroxide (78%) and with the mixture 1.5 mM hydrogen peroxide + 200 μM iodine (79%) were not able to grow on YEPG medium and, therefore, were respiratory deficient (data not shown).
The increased incidence of petite mutants indicates that the antimicrobials produce genotoxic effects. In case of hydrogen peroxide they could be associated with oxidative stress via intensive generation of reactive oxygen species that enhance mutation rates . Iodine itself did not affect spontaneous frequencies of small colonies. However, combined with hydrogen peroxide, iodine enhanced the effect of this compound (Figure 1b) suggesting some additional (possibly, co-operative) contribution to the genotoxic effect of hydrogen peroxide. Since the respiratory deficient yeast mutants are easily detectable, this approach could be potentially used for scoring genotoxic effects of any other antimicrobials (including new ones) - based on numbers of small colonies appearing after treatments. The enhanced genotoxicity itself could contribute to stronger biocidal effects against microorganisms. On the other hand, genotoxicity might increase chances for microbial mutations of drug resistance. However, the biocidal activity of the combined antimicrobials at appropriate concentrations would prevent the survival of mutants. The other potential issue is genotoxicity of antimicrobials for human cells. Overall, interplay between these processes could be the subject of further studies.
Synergistic and additive inhibitory effects of hydrogen peroxide and iodine shown for 3 bacterial and 16 yeast species imply possibilities of more effective concurrent usage of these traditional antimicrobials in various applications. Combining these compounds often converts their individual static inhibitory effects into cidal effects. Synergism is also manifested in higher frequencies of respiratory deficient yeast cells suggesting enhanced genotoxicity of the mixed antimicrobials.
Strains and culture conditions
3 bacterial and 16 yeast species were used (Additional file 1: Table S1). Bacteria were cultivated on nutrient agar or in nutrient broth for one day at 37°C. Yeasts were cultivated on solid or liquid YEPD (yeast extract, peptone, dextrose) medium at 30°C for 2 days or at 23°C for 3 days. Fresh yeast cultures were used to inoculate liquid YEPD medium at densities about 5×105 cells/ml. Single colonies of bacterial strains cultivated on nutrient agar at 37°C for 16–18 hours were used for inoculating nutrient broth at densities of approximately 5×105 cells/ml.
Fresh yeast cells grown in YEPD were resuspended in sterile distilled water to OD ~ 0.5 at 660 nm. 5 fold serial dilutions of each strain in 96-well plates (200 μl each) were plated in two replicas with Sigma-Aldrich plater onto YEPD plates with iodine and/or hydrogen peroxide, or without them. Plates were incubated at 23°C for 3 days.
Determination of minimum inhibitory concentration (MIC)
MIC values were determined separately for hydrogen peroxide and iodine (Sigma). The aqueous stock solution of iodine (product number 318981) contained KI as a solubility stabiliser. 2 ml of cultures (5×105 cells/ml) were added to test tubes, and different amounts from serial dilutions of 1 M H2O2 or 50 mM I2 stock solutions were added to the cultures to obtain a range of concentrations (10 μM - 10 mM for H2O2, and 10 μM - 1 mM for I2). Cultures were incubated at 30°C for 2 days (yeast) and at 37°C for 1–2 days (bacteria) to determine MICs (the lowest concentrations preventing growth).
Determination of the interaction mode between hydrogen peroxide and iodine
To determine MICs for individual mixtures of both compounds, serial dilutions of H2O2 and I2 were combined in test tubes containing 2 ml of cultures (~5×105 cells/ml). Cultures were incubated at 30°C for 2 days (yeast) or at 37°C for 1–2 days (bacteria). MIC values for each H2O2-I2 mixture were determined as described above. Fractional inhibitory concentration (FIC) of each compound was calculated according to the formula: FIC = MIC of a compound in a mix/MIC of a compound alone [26, 36]. The sum of fractional inhibitory concentrations (FICs) was calculated as follows: FICs = FIC hydrogen peroxide + FIC iodine FICs indices less than 1 were interpreted as weak synergistic interactions or strong additive effects.
Tests for growth recovery after inhibition with biocides
To test if growth inhibition was caused by cell death or by static inhibition of cell divisions, cells were washed from biocides 2 times with nutrient broth (for bacteria) or sterile distilled water (for yeast), and their serial dilutions were plated on freshly poured solid media for counting colonies after 1 and 2 days of growth at 30°C (yeast) and 37°C (bacteria).
Testing respiratory status of S. cerevisiae clones
Water suspensions of randomly selected individual small colonies were patched onto two types of solid media: YEPD (containing glucose, 2%) and YEPG (containing glycerol, 3%). Plates were incubated for 2.5-3 days at 30°C. Cells growing only on YEPD (fermentation conditions) but not growing on YEPG (respiration conditions) were classified as respiratory deficient mutants; cells growing on both media were considered as respiratory proficient .
Quantitative data were presented as means and standard deviations (SD). Differences with P values less than 0.05 determined in t-tests were considered as significant.
McDonnell G, Russell AD: Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999, 12 (1): 147-179.
Bowler PG, Duerden BI, Armstrong DG: Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001, 14 (2): 244-269. 10.1128/CMR.14.2.244-269.2001.
Mermel LA: Prevention of intravascular catheter-related infections. Ann Intern Med. 2000, 132 (5): 391-402. 10.7326/0003-4819-132-5-200003070-00009.
Durani P, Leaper D: Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J. 2008, 5 (3): 376-387. 10.1111/j.1742-481X.2007.00405.x.
Falagas ME, Thomaidis PC, Kotsantis IK, Sgouros K, Samonis G, Karageorgopoulos DE: Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect. 2011, 78 (3): 171-177. 10.1016/j.jhin.2010.12.006.
Kanno T, Nakamura K, Ikai H, Kikuchi K, Sasaki K, Niwano Y: Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide. J Clin Biochem Nutr. 2012, 51 (1): 9-14. 10.3164/jcbn.11-105.
Cutting KF, Butcher M: DACC antimicrobial technology: a new paradigm in bioburden management. J Wound Care. 2011, 20 (5): 1-19.
Mueller RS, Bergvall K, Bensignor E, Bond R: A review of topical therapy for skin infections with bacteria and yeast. Vet Dermatol. 2012, 23 (4): 330-e362. 10.1111/j.1365-3164.2012.01057.x.
Cutting KF: A dedicated follower of fashion? topical medications and wounds. Br J Community Nurs. 2001, 6 (8): 9-16.
Cutting KF: Wound healing through synergy of hyaluronan and an iodine complex. J Wound Care. 2011, 20 (9): 424-430.
O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG: Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2010, 10: 1-79.
Tschudin-Sutter S, Frei R, Egli-Gany D, Eckstein F, Valderrabano V, Dangel M, Battegay M, Widmer AF: No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1014 cases a prospective observational study. Ann Surg. 2012, 255 (3): 565-569. 10.1097/SLA.0b013e3182468b2d.
Eley BM: Antibacterial agents in the control of supragingival plaque - a review. Br Dent J. 1999, 186 (6): 286-296.
Presterl E, Suchomel M, Eder M, Reichmann S, Lassnigg A, Graninger W, Rotter M: Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother. 2007, 60 (2): 417-420. 10.1093/jac/dkm221.
Atakan IH, Kaplan M, Kaya E, Aktoz T, Inci O: A life-threatening infection: Fournier's gangrene. Int Urol Nephrol. 2002, 34 (3): 387-392. 10.1023/A:1024427418743.
Jansen B, Kristinsson KG, Jansen S, Peters G, Pulverer G: In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. J Antimicrob Chemother. 1992, 30 (2): 135-139. 10.1093/jac/30.2.135.
Malik DJ, Shaw CM, Rielly CD, Shama G: The inactivation of Bacillus subtilis spores at low concentrations of hydrogen peroxide vapour. J Food Eng. 2013, 114 (3): 391-396. 10.1016/j.jfoodeng.2012.08.031.
Arndt RE, Wagner EJ, Routledge MD: Reducing or withholding hydrogen peroxide treatment during a critical stage of rainbow trout development: effects on eyed eggs, hatch, deformities, and fungal control. North Am J Aquaculture. 2001, 63 (2): 161-166. 10.1577/1548-8454(2001)063<0161:ROWHPT>2.0.CO;2.
Wagner EJ, Oplinger RW, Bartley M: Laboratory and production scale disinfection of salmonid eggs with hydrogen peroxide. North Am J Aquaculture. 2012, 74 (1): 92-99. 10.1080/15222055.2011.649888.
Ukuku DO, Bari ML, Kawamoto S, Isshiki K: Use of hydrogen peroxide in combination with nisin, sodium lactate and citric acid for reducing transfer of bacterial pathogens from whole melon surfaces to fresh-cut pieces. Int J Food Microbiol. 2005, 104 (2): 225-233. 10.1016/j.ijfoodmicro.2005.01.016.
Kim BR, Anderson JE, Mueller SA, Gaines WA, Kendall AM: Literature review - efficacy of various disinfectants against Legionella in water systems. Water Res. 2002, 36 (18): 4433-4444. 10.1016/S0043-1354(02)00188-4.
Carlsson J, Edlund MB, Hanstrom L: Bactericidal and cytotoxic effects of hypothiocyanite-hydrogen peroxide mixtures. Infect Immun. 1984, 44 (3): 581-586.
Miyasaki KT, Genco RJ, Wilson ME: Antimicrobial properties of hydrogen peroxide and sodium bicarbonate individually and in combination against selected oral, gram-negative, facultative bacteria. J Dent Res. 1986, 65 (9): 1142-1148. 10.1177/00220345860650090601.
Humphrey TJ: The synergistic inhibition of Campylobacter jejuni by rifampicin and hydrogen peroxide. Lett Appl Microbiol. 1990, 10 (2): 97-100. 10.1111/j.1472-765X.1990.tb00274.x.
Almeida CEB, Felicio DL, Galhardo RS, Cabral-Neto JB, Leitao AC: Synergistic lethal effect between hydrogen peroxide and neocuproine (2,9-dimethyl 1,10-phenanthroline) in Escherichia coli. Mutation Research-DNA Repair. 1999, 433 (1): 59-66. 10.1016/S0921-8777(98)00064-0.
Steinberg D, Heling I, Daniel I, Ginsburg I: Antibacterial synergistic effect of chlorhexidine and hydrogen peroxide against Streptococcus sobrinus, Streptococcus faecalis and Staphylococcus aureus. J Oral Rehabil. 1999, 26 (2): 151-156. 10.1046/j.1365-2842.1999.00343.x.
Martin H, Maris P: Synergism between hydrogen peroxide and seventeen acids against six bacterial strains. J Appl Microbiol. 2012, 113 (3): 578-590. 10.1111/j.1365-2672.2012.05364.x.
Shama G: Inactivation of Escherichia coli by ultraviolet light and hydrogen peroxide in a thin film contactor. Lett Appl Microbiol. 1992, 15 (6): 259-260. 10.1111/j.1472-765X.1992.tb00778.x.
Markum E, Baillie J: Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of Molluscum Contagiosum in children. J Drugs Dermatol. 2012, 11 (3): 349-354.
Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML: Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am J Infect Control. 2010, 38 (10): 826-831. 10.1016/j.ajic.2010.06.022.
Price SL, Huddersman KD, Shen J, Walsh SE: Mycobactericidal activity of hydrogen peroxide activated by a novel heterogeneous fentons-like catalyst system. Lett Appl Microbiol. 2013, 56 (2): 83-87. 10.1111/lam.12010.
Voboril R, Weberova J: Successful treatment of infected vascular prosthetic grafts in the groin using conservative therapy with povidone-iodine solution. Ann Vasc Surg. 2004, 18 (3): 372-375. 10.1007/s10016-004-0024-7.
Ulivieri S, Toninelli S, Petrini C, Giorgio A, Oliveri G: Prevention of post-operative infections in spine surgery by wound irrigation with a solution of povidone-iodine and hydrogen peroxide. Arch Orthop Trauma Surg. 2011, 131 (9): 1203-1206. 10.1007/s00402-011-1262-0.
Ng SM, Wieckowski S: Stable hydrogen peroxide dental gel. US Patent-4839156. 1989, Colgate-Palmolive Company, 1199
Cassee FR, Groten JP, van Bladeren PJ, Feron VJ: Toxicological evaluation and risk assessment of chemical mixtures. Crit Rev Toxicol. 1998, 28 (1): 73-101. 10.1080/10408449891344164.
Chung PY, Navaratnam P, Chung LY: Synergistic antimicrobial activity between pentacyclic triterpenoids and antibiotics against Staphylococcus aureus strains. Ann Clin Microbiol Antimicrob. 2011, 10 (25): 1-6.
Hall MJ, Middleton RF, Westmacott D: The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother. 1983, 11: 427-433. 10.1093/jac/11.5.427.
Burkhart CG, Burkhart CN, Isham N: Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species. Br J Dermatol. 2006, 154 (2): 341-344. 10.1111/j.1365-2133.2005.06924.x.
Fraunfelder FW, Rich LF: Possible adverse effects of drugs used in refractive surgery. J Cataract Refract Surg. 2003, 29 (1): 170-175. 10.1016/S0886-3350(02)01836-9.
Tredwin CJ, Naik S, Lewis NJ, Scully C: Hydrogen peroxide tooth-whitening (bleaching) products: review of adverse effects and safety issues. Br Dent J. 2006, 200 (7): 371-376. 10.1038/sj.bdj.4813423.
Oberg TS, Steele JL, Ingham SC, Smeianov VV, Briczinski EP, Abdalla A, Broadbent JR: Intrinsic and inducible resistance to hydrogen peroxide in Bifidobacterium species. J Ind Microbiol Biotechnol. 2011, 38 (12): 1947-1953. 10.1007/s10295-011-0983-y.
Brown ML, Aldrich HC, Gauthier JJ: Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl Environ Microbiol. 1995, 61 (1): 187-193.
Bulder CJEA: Induction of petite mutation and inhibition of synthesis of respiratory enzymes in various yeasts. Antonie Van Leeuwenhoek. 1964, 30: 1-9. 10.1007/BF02046695.
Orrenius S, Gogvadze A, Zhivotovsky B: Mitochondrial oxidative stress: Implications for cell death. Annual Review of Pharmacology and Toxicology. 2007, Palo Alto: Annual Reviews, 143-183. 47
Rodger G, Taylor RL, Pearson GJ, Verran J: In Vitro colonization of an experimental silicone by Candida albicans. J Biomed Mater Res B Appl Biomater. 2010, 92B (1): 226-235. 10.1002/jbm.b.31509.
Zubko MK, Lydall D: Linear chromosome maintenance in the absence of essential telomere-capping proteins. Nat Cell Biol. 2006, 8 (7): 734-740. 10.1038/ncb1428.
We thank the Faculty of Science and Engineering for providing financial start-up support for this work, and Dr. Gordon Craig (School of Science &The Environment at MMU) for reading the manuscript. We also thank anonymous reviewers for their constructive suggestions.
The authors declare that they have no competing interests.
EIZ and MKZ designed the study. EIZ has performed predominant part of experiments. MKZ did spot tests and wrote the bulk of the manuscript. EIZ calculated data and made tables and figures. Both authors approved the final version of the manuscript.
Electronic supplementary material
Additional file 1: Table S1: Microorganisms used in the study. [45, 46]. (DOCX 18 KB)
Additional file 3: Figure S1: Growth responses of P. aeruginosa to different concentrations of I2(a), H2O2(b) and mixtures of I2 and H2O2 at different concentrations in nutrient broth (c). (d) Recovery of the growth after inhibition with individual and mixed compounds. 20 μl from undiluted cultures and from two different dilutions (100 fold and 1000 fold) were plated on each plate and grown overnight at 37°C, with further checking on the next day. Figure S2. Growth responses (growth or no growth) of S. aureus to different concentrations of I2(a), H2O2(b) and mixtures of I2 and H2O2 at different concentrations in nutrient broth (c). (d) Recovery of the growth after inhibition with individual and mixed compounds. 20 μl from undiluted cultures and from two different dilutions (100 fold and 1000 fold) were plated on each plate and grown overnight at 37°C, with further checking on the next day. Figure S3. Growth responses (growth or no growth) of S. cerevisiae to different concentrations of I2(a), H2O2(b) and mixtures of I2 and H2O2 at different concentrations in YEPD liquid medium (c). (d) Recovery of the growth after inhibition with individual and mixed compounds. Before plating cultures were diluted 1000 times and 100 times. In cases of mixed compounds, both diluted and undiluted cultures were plated. The plated were incubated for 2 days at 30°C. Figure S4. Growth responses (growth or no growth) of E. coli to different concentrations of I2(a), H2O2(b) and mixtures of I2 and H2O2 at different concentrations in nutrient broth (c). (d) Recovery of the growth after inhibition with individual and mixed compounds. 20 μl from undiluted cultures and from two different dilutions (100 fold and 1000 fold) were plated on each plate and grown overnight at 37°C, with further checking on the next day. (PPT 1 MB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.